Oncology & Cancer

Elevated hormone levels add up to increased breast cancer risk

Post-menopausal women with high levels of hormones such as estrogen or testosterone are known to have a higher risk of breast cancer. New research published in BioMed Central's open access journal Breast Cancer Research looked ...

Neuroscience

The eyes have it: Men do see things differently to women

The way that the visual centers of men and women's brains works is different, finds new research published in BioMed Central's open access journal Biology of Sex Differences. Men have greater sensitivity to fine detail and ...

Health

Commuting - bad for your health?

A mobile workforce can help improve a country's economy but the effects of commuting on the health of commuters and on the costs to industry in terms of sick days is largely unknown. From a commuter's point of view, the advantages ...

Medical research

Proteins used to map the aging process

Loss of muscle mass is not only associated with disease, such as HIV and cancer, but also with the normal aging process. Anabolic steroids are sometimes used to reverse loss of lean muscle tissue but they can have unwanted ...

Arthritis & Rheumatism

Ultra short telomeres linked to osteoarthritis

Telomeres, the very ends of chromosomes, become shorter as we age. When a cell divides it first duplicates its DNA and, because the DNA replication machinery fails to get all the way to the end, with each successive cell ...

Medical research

Stem cell therapy reverses diabetes

Type 1 diabetes is caused by the body's own immune system attacking its pancreatic islet beta cells and requires daily injections of insulin to regulate the patient's blood glucose levels. A new method described in BioMed ...

page 1 from 18

BioMed Central

BioMed Central (BMC) is a UK-based for-profit scientific publisher specializing in open access publication. BMC publishes over 180 scientific journals, and describes itself as the first and largest open access science publisher. BMC sister companies publish the Chemistry Central and PhysMath Central journals. The Chairman is Vitek Tracz and the Publisher is Matt Cockerill.

Most titles are open access, including its flagship journals Journal of Biology, Molecular Cancer Malaria Journal, the innovative Journal of Negative Results in BioMedicine and the BMC journal series including the leading titles BMC Biology and BMC Medicine. Others are open access for the research articles portion only, such as Genome Biology, Arthritis Research & Therapy, Breast Cancer Research, andCritical Care. Some review titles, such as Current Opinion in Drug Discovery & Development are entirely subscription based. Open access content is released under the Creative Commons "Attribution" license which grants permission to reuse publications and produce derivative work.

In October 2008, it was announced that BMC, Chemistry Central, and PhysMath Central, had been acquired by Springer Science+Business Media. Previously, since its creation, the company was part of Science Navigation Group, chaired by Vitek Tracz, which also owns The Scientist (a popular science magazine—the daily news section is free access; the remainder is by subscription), Faculty of 1000 (a subscription-only current awareness service highlighting recent biological research), Global DataPoint, People's Archive and, in the past, two other companies which had previously been acquired by Springer, Images.MD (a medical image database) and Current Medicine.

In November 2008, BMC became an official supporting organisation of HIFA2015 (Healthcare Information For All by 2015).

This text uses material from Wikipedia, licensed under CC BY-SA